Rchr
J-GLOBAL ID:201901014452959174   Update date: Nov. 03, 2024

Zhou Yue

Zhou Yue
Research field  (1): Pharmaceuticals - health and biochemistry
Research keywords  (2): 受容体型チロシンキナーゼ ,  シグナル伝達
Research theme for competitive and other funds  (4):
  • 2022 - 2025 MK2を介した非定型的活性型EphA2によるがん悪性進展の制御機構
  • 2022 - 2025 Cancer pathophysiology and treatment from the perspective of dual-mode control of EGFR
  • 2020 - 2023 がん微小環境におけるVEGFR3非定型的活性化機構の解明
  • 2019 - 2021 Regulation of epithelial-mesenchymal transition and cancer stemness by the non-canonical activation of EphA2.
Papers (44):
  • Yutaka Yasuta, Ryuya Kaminaka, Shutaro Nagai, Shuto Mouri, Katsuya Ishida, Akihiro Tanaka, Yue Zhou, Hiroaki Sakurai, Satoru Yokoyama. Cooperative function of oncogenic MAPK signaling and the loss of Pten for melanoma migration through the formation of lamellipodia. Scientific Reports. 2024. 14. 1
  • Yue Zhou, Jun-Ichiro Takahashi, Hiroaki Sakurai. New Directions for Advanced Targeting Strategies of EGFR Signaling in Cancer. Biological & pharmaceutical bulletin. 2024. 47. 5. 895-903
  • Yue Zhou, Ryota Oki, Akihiro Tanaka, Leixin Song, Atsushi Takashima, Naru Hamada, Satoru Yokoyama, Seiji Yano, Hiroaki Sakurai. Cellular stress induces non-canonical activation of the receptor tyrosine kinase EphA2 through the p38-MK2-RSK signaling pathway. Journal of Biological Chemistry. 2023. 299. 5
  • Aki Kohyama, Aya Shiuchi, Yue Zhou, Masaru Tanioka, Kenji Sugimoto, Hiroaki Sakurai, Yuji Matsuya. Controllable conformation and reactivity of bicyclic α-methylene cyclopentanones and their NF-κB pathway inhibitory activity. Organic & Biomolecular Chemistry. 2023. 21. 22. 4656-4660
  • Jun-Ichiro Takahashi, Shiori Nakamura, Iimi Onuma, Yue Zhou, Satoru Yokoyama, Hiroaki Sakurai. Synchronous intracellular delivery of EGFR-targeted antibody-drug conjugates by p38-mediated non-canonical endocytosis. Scientific reports. 2022. 12. 1. 11561-11561
more...
MISC (13):
  • 岩原宏幸, 岩田悠輔, 名取香奈子, 小澤龍彦, ZHOU Yue, 定清直, 横山悟, 櫻井宏明. Phosphorylation of TAB1 by Src: A new signaling pathway of oxidative stress. 衛生薬学・環境トキシコロジー講演要旨集. 2020. 2020
  • Sakurai H., Tanaka T., Zhou Y. A new mechanism of EGFR activation based on Phos-tag analysis. Abstracts for Annual Meeting of Japanese Proteomics Society. 2019. 2019. 124-124
  • 中嶋 一裕, 周 越, 富田 亜希子, 平出 祥啓, 中田 慎一郎. ゲノム恒常性維持機構の破綻と疾患発症の分子メカニズム ニックによる正確で効率のよいゲノム編集法では非古典的なHDRが利用されている. 生命科学系学会合同年次大会. 2017. 2017年度. [3PW02-4]
  • 河崎優希, 崎村綾香, パク チョルミン, 都丸里佳, 小澤龍彦, 周越, 成田香織, 村口篤, 櫻井宏明. ErbB2/ErbB3ヘテロ二量体におけるERKを介したErbB2Thr-677リン酸化によるフィードバック制御. 日本分子生物学会年会プログラム・要旨集(Web). 2016. 39th
  • 河崎 優希, 崎村 綾香, Park Chulmin, 周 越, 都丸 里佳, 成田 香織, 小澤 龍彦, 村口 篤, 櫻井 宏明. ERKを介したErbB2 Thr-677リン酸化によるErbB2/ErbB3ヘテロ二量体のフィードバック阻害機構. 日本生化学会大会・日本分子生物学会年会合同大会講演要旨集. 2015. 88回・38回. [2P0209]-[2P0209]
more...
Education (3):
  • 2011 - 2014 University of Toyama Graduate School of Medicine and Pharmaceutical Sciences for Education
  • 2009 - 2011 University of Toyama Graduate School of Medicine and Pharmaceutical Sciences for Education
  • 2005 - 2009 University of Toyama Faculty of Pharmacy and Pharmaceutical Sciences
Professional career (1):
  • 博士(薬学) (富山大学)
Work history (5):
  • 2019/04 - 現在 University of Toyama
  • 2016/01 - 2019/03 上海中医薬大学 中薬研究所 副研究員
  • 2015/04 - 2015/12 Osaka University Graduate School of Medicine
  • 2014/07 - 2015/03 University of Toyama Graduate School of Medicine and Pharmaceutical Sciences for Research
  • 2014/04 - 2014/06 University of Toyama Graduate School of Medicine and Pharmaceutical Sciences for Research
Association Membership(s) (6):
日本生化学会 ,  日本薬学会 ,  日本がん転移学会 ,  THE MOLECULAR BIOLOGY SOCIETY OF JAPAN ,  THE JAPANESE ASSOCIATION FOR MOLECULAR TARGET THERAPY OF CANCER ,  THE JAPANESE CANCER ASSOCIATION
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page